Cargando…
Long-acting Neuraminidase Inhibitor Laninamivir Octanoate as Post-exposure Prophylaxis for Influenza
Background. A single administration of laninamivir octanoate, a long-acting neuraminidase inhibitor, has been proven to be effective in the treatment of influenza but not for post-exposure prophylaxis. Methods. We conducted a double-blind, multicenter, randomized, placebo-controlled study to determi...
Autores principales: | Kashiwagi, Seizaburo, Watanabe, Akira, Ikematsu, Hideyuki, Uemori, Mitsutoshi, Awamura, Shinichiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4946013/ https://www.ncbi.nlm.nih.gov/pubmed/27118785 http://dx.doi.org/10.1093/cid/ciw255 |
Ejemplares similares
-
Laninamivir octanoate for post-exposure prophylaxis of influenza in household contacts: a randomized double blind placebo controlled trial
por: Kashiwagi, Seizaburo, et al.
Publicado: (2013) -
Effects of Vaccination and the New Neuraminidase Inhibitor, Laninamivir, on Influenza Infection
por: Mizuno, Takuro, et al.
Publicado: (2014) -
Immune-mediated Drug-induced Liver Injury Caused by Laninamivir Octanoate Hydrate
por: Kawaguchi, Toshihiro, et al.
Publicado: (2019) -
Structural and Functional Analysis of Laninamivir and its Octanoate Prodrug Reveals Group Specific Mechanisms for Influenza NA Inhibition
por: Vavricka, Christopher J., et al.
Publicado: (2011) -
Comparison of the clinical effectiveness of zanamivir and laninamivir octanoate for children with influenza A(H3N2) and B in the 2011–2012 season
por: Koseki, Naoko, et al.
Publicado: (2014)